{"id":"W4384134428","doi":"10.58931/cht.2023.2124","title":"Tyrosine kinase inhibitors for the frontline management of CML: an overview","year":2023,"lang":"en","type":"article","venue":"Canadian Hematology Today","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Imatinib; Ponatinib; Tyrosine kinase; Myeloid leukemia; Tyrosine-kinase inhibitor; Drug holiday; Internal medicine; Oncology; Population; Pharmacology; Immunology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005982863,0.0005908326,0.0004962027,0.001852433,0.0003531798,0.0009875882,0.0004896891,0.0008611086,0.002962361],"category_scores_gemma":[0.0005095923,0.0001413993,0.0004652044,0.001263182,0.0002603778,0.001111063,0.0004249589,0.001920989,0.001075105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001145691,"about_ca_system_score_gemma":0.00167751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00314142,"about_ca_topic_score_gemma":0.01430428,"domain_scores_codex":[0.9997732,0.00004168481,0.00002470471,0.00002385166,0.0001009149,0.00003563244],"domain_scores_gemma":[0.9997318,0.00008341774,0.00003729001,0.000004963122,0.00008969685,0.00005267803],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001039977,0.0001285376,0.0005786744,0.003977493,0.00006282226,0.0004125031,0.00008187904,0.0002355311,0.001425705,0.004277827,0.04546273,0.9432522],"study_design_scores_gemma":[0.0000330359,0.0002230144,0.001855333,0.002347576,0.0001015901,0.002257702,0.00006995963,0.0001742744,0.0003295725,0.001263642,0.9913293,0.00001494076],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005074063,0.9905751,0.0003810012,0.002876956,0.0003105993,0.00001895051,0.00002744732,0.00001511702,0.005287567],"genre_scores_gemma":[0.002058292,0.9944622,0.000878434,0.0009592746,0.0004910317,0.00001331113,0.00004787361,0.00000262253,0.001086968],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00314142,"threshold_uncertainty_score":0.009910047,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04892717281739035,"score_gpt":0.3194743769551006,"score_spread":0.2705472041377102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}